FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Achim Jungbluth

Research Profile

Chemicals & Drugs

Procedures

Disorders

Anatomy

Physiology

Gene Expression Regulation, Neoplastic

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Patrick A Ott; Linda Pan; Neeta Pandit-Taskar; Anna Pavlick; Ralph Venhaus; John S Bomalaski; Richard D Carvajal; Eric W Hoffman; Achim A Jungbluth; Lloyd J Old; Bor-Wen Wu; Jedd D Wolchok
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
Klaus J Busam; Cyrus Hedvat; Melissa Pulitzer; Andreas von Deimling; Achim A Jungbluth
Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Eleanor M Tyler; Richard J O'Reilly; Achim A Jungbluth; Guenther Koehne
WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Achim Jungbluth (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Patrick A Ott; Linda Pan; Neeta Pandit-Taskar; Anna Pavlick; Ralph Venhaus; John S Bomalaski; Richard D Carvajal; Eric W Hoffman; Achim A Jungbluth; Lloyd J Old; Bor-Wen Wu; Jedd D Wolchok
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
Investigational new drugs 2013;31(2):425-34.
2013: Klaus J Busam; Cyrus Hedvat; Melissa Pulitzer; Andreas von Deimling; Achim A Jungbluth
Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
The American journal of surgical pathology 2013;37(3):413-20.
2013: Eleanor M Tyler; Richard J O'Reilly; Achim A Jungbluth; Guenther Koehne
WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions.
Blood 2013;121(2):308-17.
2013: ROBERT G MAKI; Lloyd J Old; Erika Ritter; Rita Chiu; David R D'Adamo; Sacha Gnjatic; Achim A Jungbluth; Jennifer Kachel; Mary-Louise Keohan; Israel Lowy; Kelly Scheu; Gary K Schwartz; Michael J Wagner; Gerd Ritter
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
Sarcoma 2013;2013():168145.
2013: Lars Stelter; Pat Zanzonico; Valerie A Longo; Lloyd Old; Gerd Ritter; John S Bomalaski; Michael J Evans; Achim A Jungbluth; Steven M Larson
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
Molecular imaging 2013;12(1):67-73.
2012: Paul Sabbatini; Andres M Salazar; Christine Sedrak; David Spriggs; William P Tew; Takemasa Tsuji; Kevin Tuballes; Ralph Venhaus; Martee Hensley; Eric W Hoffman; Achim A Jungbluth; Jason Konner; Lloyd J Old; Linda Pan; Erika Ritter; Gerd Ritter; Carol Aghajanian; Katherine Bell-McGuinn; Catherine Magid Diefenbach; Luis Ferran; Sacha Gnjatic
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(23):6497-508.
2012: Riguel Jun Inaoka; Achim A Jungbluth; Erika Ritter; Jodie Tassello; Leina Y Etto; Denise Frosina; Sacha Gnjatic; Nicole C Hanson; Antonio C Alves; Adriana B Bortoluzzo; Gisele W B Colleoni
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.
Cancer immunology, immunotherapy : CII 2012;61(12):2207-14.
2012: Seth M Pollack; Eve Rodler; David J Schneider; Marie Bleakley; Janet F Eary; Erik A Farrar; Benjamin L Hoch; Robin L Jones; Achim A Jungbluth; Elizabeth T Loggers; Ernest U Conrad; Cassian Yee
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
Cancer 2012;118(18):4564-70.
2012: José Raphael de Moura Campos Montoro; Luciano Neder Serafini; Fabiano P Saggioro; Wilson Araújo Silva Jr; Giulio C Spagnoli; David Livingstone Alves Figueiredo; Achim A Jungbluth; Rui Celso Martins Mamede; Marco Zago
Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma.
Head & neck 2012;34(8):1123-8.
2012: Takemasa Tsuji; Otavia L Caballero; Achim A Jungbluth; Junko Matsuzaki; Kunle Odunsi; Lloyd J Old; Gerd Ritter; Sacha Gnjatic
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(8):3851-8.
2012: Michael A Postow; Teresa Rasalan; Erika Ritter; Ruth-Ann Roman; Samuel Rosner; Christine Sedrak; Yoshiya Yamada; Arvin S Yang; Jianda Yuan; Matthew Adamow; James P Allison; Christopher A Barker; Brenna Benson; Margaret K Callahan; Ramon Chua; Sacha Gnjatic; Achim A Jungbluth; Shigehisa Kitano; Alexander M Lesokhin; Zhenyu Mu; Jedd D Wolchok
Immunologic correlates of the abscopal effect in a patient with melanoma.
The New England journal of medicine 2012;366(10):925-31.
2012: Erica C Rushing; Sofia Shea; Megan J Stine; William H Westra; Klaus J Busam; Mark S Eller; Sarah J Hahn; Achim A Jungbluth; Sarika Khanna; Meera Mahalingam; Alaa Naif; Rhoda M Alani
Neuropilin-2: a novel biomarker for malignant melanoma?
Human pathology 2012;43(3):381-9.
2012: Lars Stelter; Pat Zanzonico; Lloyd Old; Gerd Ritter; Eric Rosenfeld; John S Bomalaski; Michael J Evans; Achim A Jungbluth; Thomas Ku; Steven M Larson
Novel mechanistic insights into arginine deiminase pharmacology suggest 18F-FDG is not suitable to evaluate clinical response in melanoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(2):281-6.
2012: Junji Kawada; Hiroshi Miyata; Naoaki Mizuno; Roger Murphy; Yurika Nakamura; Yuichiro Doki; Shinichi Fujiwara; Sacha Gnjatic; Midori Isobe; Achim A Jungbluth; Hiroyoshi Nishikawa; Nami Okazaki; Lloyd J Old; Linda Pan; Erika Ritter; Gerd Ritter; Takashi Saika; Akiko Uenaka; Ralph Venhaus; Hisashi Wada; Makoto Yamasaki; Eiichi Nakayama
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2012;130(3):584-92.
2011: Caroline Junqueira; Lloyd J Old; Gerd Ritter; Flávia G Rodrigues; Luara I Santos; Santuza M R Teixeira; Egler Chiari; Wanderson D DaRocha; Bruno Galvão-Filho; Sacha Gnjatic; Achim A Jungbluth; Ricardo T Gazzinelli
Trypanosoma cruzi as an effective cancer antigen delivery vector.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(49):19695-700.
2011: Joseph A O'Donoghue; Lloyd J Old; Neeta Pandit-Taskar; Daniel A Pryma; Shutian Ruan; Peter Smith-Jones; Vivian E Strong; Jorge Carrasquillo; Chaitanya R Divgi; Yuman Fong; John L Humm; Achim A Jungbluth; Nancy E Kemeny; Steven M Larson
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1878-85.
2011: Jianda Yuan; Matthew Adamow; James P Allison; Humilidad F Gallardo; Brian A Ginsberg; Ruth Halaban; Achim A Jungbluth; Deborah Kuk; Lloyd J Old; Katherine S Panageas; Evelina Pogoriler; Teresa S Rasalan; Erika Ritter; Gerd Ritter; Mario Sznol; Stephanie L Terzulli; Jedd D Wolchok; Yinyan Xu; Sacha Gnjatic
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(40):16723-8.
2011: Daniel Hardy Melo; Luciano Neder; Fabiano P Saggioro; David Livingstone Alves Figueiredo; Achim A Jungbluth; Rui Celso Martins Mamede; Wilson Araújo da Silva; Marco Zago
Expression of MAGE-A4 and MAGE-C1 tumor-associated antigen in benign and malignant thyroid diseases.
Head & neck 2011;33(10):1426-32.
2011: Jorge A Carrasquillo; Chaitanya R Divgi; Yuman Fong; Mithat Gonen; John L Humm; Jaspreet S Jaggi; Achim A Jungbluth; Nancy E Kemeny; Joseph A O'Donoghue; Lloyd J Old; Katherine S Panageas; Neeta Pandit-Taskar; Daniel A Pryma; Gerd Ritter; Shutian Ruan; David A Scheinberg; Peter Smith-Jones; Douglas Wong; Pat Zanzonico; Steven M Larson
(124)I-huA33 antibody PET of colorectal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1173-80.
2011: Moses K Donkor; Ruth A Franklin; Linda Kassebaum Johnson; Achim A Jungbluth; Abira Sarkar; Peter A Savage; James P Allison; Ming O Li
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.
Immunity 2011;35(1):123-34.
2011: Tricia Nardiello; Ruben Niesvizky; Lloyd J Old; Roger Pearse; Rebecca Wasserstrum; Valéria C C Andrade; Nina Bhardwaj; Selina Chen-Kiang; Morton Coleman; Ania Dabrowski; Maurizio Diliberto; Scott Ely; Xiangao Huang; David S Jayabalan; Achim A Jungbluth; Anna Mei; Hearn Jay Cho
MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4309-19.
2011: Sylvia Adams; Sandra Demaria; Denise Fosina; Luba Greeder; Nicole Hanson; Elsa Reich; Yongzhao Shao; Baljit Singh; Giulio C Spagnoli; Jodie Tassello; Achim A Jungbluth
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?
Cancer immunology, immunotherapy : CII 2011;60(7):999-1007.
2011: David L A Figueiredo; Rui Celso Martins Mamede; Giulio C Spagnoli; Wilson Araújo Silva Jr; Marco Zago; Luciano Neder; Achim A Jungbluth; Fabiano P Saggioro
High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx.
Head & neck 2011;33(5):702-7.
2011: Daniel A Pryma; Joseph A O'Donoghue; John L Humm; Achim A Jungbluth; Lloyd J Old; Steven M Larson; Chaitanya R Divgi
Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(4):535-40.
2011: Rolf Mentlein; Kirsten Hattermann; Charles Hemion; Achim A Jungbluth; Janka Held-Feindt
Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors.
Biological chemistry 2011;392(3):199-207.
2011: Fabricio de Carvalho; André L Vettore; Riguel J Inaoka; Bruno Karia; Valéria C C Andrade; Sacha Gnjatic; Achim A Jungbluth; Gisele W B Colleoni
Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy.
Cancer immunity 2011;11():1.
2010: Cornelia L Trimble; Rachael A Clark; Christopher Thoburn; Nicole C Hanson; Jodie Tassello; Denise Frosina; FERDYNAND KOS; Jessica Teague; Ying Jiang; Barat Nicole; Achim A Jungbluth
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(11):7107-14.
2010: Jianda Yuan; David B Page; Geoffrey Y Ku; Yanyun Li; Zhenyu Mu; Charlotte Eielson Ariyan; Humilidad F Gallardo; Ruth-Ann Roman; Agnes I Heine; Stephanie L Terzulli; Erika Ritter; Sacha Gnjatic; Gerd Ritter; Achim A Jungbluth; James P Allison; Lloyd J Old; Jedd D Wolchok
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
Cancer immunity 2010;10():1.
2009: Klaus J Busam; Achim A Jungbluth; Natasha Rekthman; Daniel G Coit; Melissa Pulitzer; Jason Bini; Reety Arora; Nicole C Hanson; Jodie A Tassello; Denise Frosina; Patrick Moore; Yuan Chang
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.
The American journal of surgical pathology 2009;33(9):1378-85.
2009: Anita Grigoriadis; Otavia L Caballero; Keith Hoek; Leonard da Silva; Yao-Tseng Chen; Sandra J Shin; Achim A Jungbluth; Lance D Miller; David Clouston; Jonathan Cebon; Lloyd J Old; Sunil R Lakhani; Andrew J G Simpson; A Munro Neville
CT-X antigen expression in human breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(32):13493-8.
2009: Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.
The Journal of investigative dermatology 2009;129(8):1972-82.
2009: Hong Chen; Chrysoula I Liakou; Ashish Kamat; Curtis A Pettaway; John Ward; Derek Ng Tang; Jingjing Sun; Achim A Jungbluth; Patricia Troncoso; Christopher Logothetis; Padmanee Sharma
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(8):2729-34.
2008: Hisashi Wada; Eiichi Sato; Akiko Uenaka; Midori Isobe; Ryohei Kawabata; Yurika Nakamura; Shigemichi Iwae; Kouichiro Yonezawa; Makoto Yamasaki; Hiroshi Miyata; Yuichiro Doki; Hiroshi Shiku; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric W Hoffman; Lloyd J Old; Morito Monden; Eiichi Nakayama
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2008;123(10):2362-9.
2008: Padmanee Sharma; Dean F Bajorin; Achim A Jungbluth; Harry W Herr; Lloyd J Old; Sacha Gnjatic
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(9):849-57.
2008: Daniel Perez; Thomas Herrmann; Achim A Jungbluth; Pierre Samartzis; Giulio Spagnoli; Nicolas Demartines; Pierre-Alain Clavien; Silvia Marino; Burkhardt Seifert; Dirk Jaeger
Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence.
International journal of cancer. Journal international du cancer 2008;123(7):1551-5.
2008: Bijal D. Amin; Kishwer S Nehal; Achim A Jungbluth; Bushra Zaidi; Mary S Brady; Daniel G Coit; Quin Zhou; Klaus J Busam
Histologic distinction between subungual lentigo and melanoma.
The American journal of surgical pathology 2008;32(6):835-43.
2008: Petra Rietschel; Jedd D Wolchok; Susan E Krown; Scott Gerst; Achim A Jungbluth; Klaus J Busam; Katherine Smith; Irene Orlow; Katherine S Panageas; Paul B Chapman
Phase II study of extended-dose temozolomide in patients with melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2299-304.
2008: Achim A Jungbluth
Serological reagents for the immunohistochemical analysis of melanoma metastases in sentinel lymph nodes.
Seminars in diagnostic pathology 2008;25(2):120-5.
2008: Catherine S M Diefenbach; Sacha Gnjatic; Paul Sabbatini; Carol Aghajanian; Martee Hensley; David Spriggs; Alexia Iasonos; Helen Lee; Bo Dupont; Sandra Pezzulli; Achim A Jungbluth; Lloyd J Old; Jakob Dupont
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2740-8.
2008: Peter A Savage; Keith Vosseller; Chulho Kang; Kevin Larimore; Elyn Riedel; Kathleen Wojnoonski; Achim A Jungbluth; James P Allison
Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.
Science (New York, N.Y.) 2008;319(5860):215-20.
2008: Sueli M Oba-Shinjo; Otavia L Caballero; Achim A Jungbluth; Sérgio Rosemberg; Lloyd J Old; Andrew J G Simpson; Suely K N Marie
Cancer-testis (CT) antigen expression in medulloblastoma.
Cancer immunity 2008;8():7.
2008: Beatrice W T Yin; Ramziya Kiyamova; Ramon Chua; Otavia L Caballero; Ivan T Gout; Vitalina Gryshkova; Nimesh Bhaskaran; Serhiy Souchelnytskyi; Ulf Hellman; Valeriy Filonenko; Achim A Jungbluth; Kunle Odunsi; Kenneth O Lloyd; Lloyd J Old; Gerd Ritter
Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.
Cancer immunity 2008;8():3.
2007: Jean-Philippe Theurillat; Ursina Zürrer-Härdi; Zsuzsanna Varga; Martina Storz; Nicole M Probst-Hensch; Burkhardt Seifert; Mathias K Fehr; Daniel Fink; Soldano Ferrone; Bernhard C Pestalozzi; Achim A Jungbluth; Yao-Tseng Chen; Dirk Jäger; Alexander Knuth; Holger Moch
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Cancer immunology, immunotherapy : CII 2007;56(11):1723-31.
2007: Lee M Krug; Daniel T Milton; Achim A Jungbluth; Lin-Chi Chen; Emilio Quaia; Neeta Pandit-Taskar; Andrew Nagel; Jessica Jones; Mark G Kris; Ronald Finn; Peter Smith-Jones; Andrew M Scott; Lloyd J Old; Chaitanya R Divgi
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):947-52.
2007: Inka Seil; Claudia Frei; Holger Sültmann; Shirley K Knauer; Knut Engels; Elke Jäger; Kurt Zatloukal; Michael Pfreundschuh; Alexander Knuth; Yao Tseng-Chen; Achim A Jungbluth; Roland H Stauber; Dirk Jäger
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.
International journal of cancer. Journal international du cancer 2007;120(12):2635-42.
2007: Danila Valmori; Naira E Souleimanian; Valeria Tosello; Nina Bhardwaj; Sylvia Adams; David O'Neill; Anna Pavlick; Juliet B Escalon; Crystal M Cruz; Angelica Angiulli; Francesca Angiulli; Gregory Mears; Susan M Vogel; Linda Pan; Achim A Jungbluth; Eric W Hoffmann; Ralph Venhaus; Gerd Ritter; Lloyd J Old; Maha Ayyoub
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8947-52.
2007: Chaitanya R Divgi; Neeta Pandit-Taskar; Achim A Jungbluth; Victor E Reuter; Mithat Gonen; Shutian Ruan; Christine Pierre; Andrew Nagel; Daniel A Pryma; John L Humm; Steven M Larson; Lloyd J Old; Paul Russo
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.
The lancet oncology 2007;8(4):304-10.
2007: Andrew M Scott; Fook-Thean Lee; Niall Tebbutt; Rebecca Herbertson; Sanjeev S Gill; Zhanqi Liu; Effie Skrinos; Carmel Murone; Tim Saunder; Bridget Chappell; Anthony T Papenfuss; Aurora M T Poon; Wendie Hopkins; Fiona E Smyth; Duncan MacGregor; Lawrence M Cher; Achim A Jungbluth; Gerd Ritter; Martin W Brechbiel; Roger Murphy; Antony W Burgess; Eric W Hoffman; Terrance G Johns; Lloyd J Old
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):4071-6.
2007: Padmanee Sharma; Yu Shen; Sijin Wen; Sachiko Yamada; Achim A Jungbluth; Sacha Gnjatic; Dean F Bajorin; Victor E Reuter; Harry W Herr; Lloyd J Old; Eiichi Sato
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):3967-72.
2007: Dirk Jäger; Valeriy Filonenko; Ivan T Gout; Denise Frosina; Susannah Eastlake-Wade; Sandra Castelli; Zsuzsanna Varga; Holger Moch; Yao-Tseng Chen; Klaus J Busam; Inka Seil; Lloyd J Old; Aviram Nissan; Claudia Frei; Ali O Gure; Alexander Knuth; Achim A Jungbluth
NY-BR-1 is a differentiation antigen of the mammary gland.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(1):77-83.
2007: Danan Li; Hongbin Ji; Sara Zaghlul; Kate McNamara; Mei-Chih Liang; Takeshi Shimamura; Shigeto Kubo; Masaya Takahashi; Lucian R Chirieac; Robert F Padera; Andrew M Scott; Achim A Jungbluth; Webster K Cavenee; Lloyd J Old; George D Demetri; Kwok-Kin Wong
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas.
The Journal of clinical investigation 2007;117(2):346-52.
2007: Djordje Atanackovic; Julia Arfsten; Yanran Cao; Sacha Gnjatic; Frank Schnieders; Katrin Bartels; Georgia Schilling; Christiane Faltz; Christine Wolschke; Judith Dierlamm; Gerd Ritter; Thomas Eiermann; Dieter K Hossfeld; Axel R Zander; Achim A Jungbluth; Lloyd J Old; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2007: Wilson A Silva; Sacha Gnjatic; Erika Ritter; Ramon Chua; Tzeela Cohen; Melinda Hsu; Achim A Jungbluth; Nasser K Altorki; Yao-Tseng Chen; Lloyd J Old; Andrew J G Simpson; Otavia L Caballero
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses.
Cancer immunity 2007;7():18.
2007: Achim A Jungbluth; Wilson A Silva; Kristin Iversen; Denise Frosina; Bushra Zaidi; Keren Coplan; Susannah Eastlake-Wade; Sandra B Castelli; Giulio C Spagnoli; Lloyd J Old; Martin Vogel
Expression of cancer-testis (CT) antigens in placenta.
Cancer immunity 2007;7():15.
2007: Elsa F Velazquez; Achim A Jungbluth; Molly Yancovitz; Sacha Gnjatic; Sylvia Adams; David O'Neill; Kira Zavilevich; Tatyana Albukh; Paul J Christos; Madhu Mazumdar; Anna Pavlick; David Polsky; Richard Shapiro; Russell Berman; Joanna Spira; Klaus J Busam; Iman Osman; Nina Bhardwaj
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.
Cancer immunity 2007;7():11.
2007: Akiko Uenaka; Hisashi Wada; Midori Isobe; Takashi Saika; Kazuhide Tsuji; Eiichi Sato; Shuichiro Sato; Yuji Noguchi; Ryohei Kawabata; Takushi Yasuda; Yuichiro Doki; Hiromi Kumon; Keiji Iwatsuki; Hiroshi Shiku; Morito Monden; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric Hoffman; Lloyd J Old; Eiichi Nakayama
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Cancer immunity 2007;7():9.
2007: PETER NELSON; Paul J Zhang; Giulio C Spagnoli; John E Tomaszewski; Theresa L Pasha; Denise Frosina; Otavia L Caballero; Andrew J G Simpson; Lloyd J Old; Achim A Jungbluth
Cancer/testis (CT) antigens are expressed in fetal ovary.
Cancer immunity 2007;7():1.
2006: Junichi Sakamoto; Noboru Oriuchi; Erito Mochiki; Takayuki Asao; Andrew M Scott; Eric W Hoffman; Achim A Jungbluth; Takanori Matsui; Fook-Thean Lee; Anthony T Papenfuss; Hiroyuki Kuwano; Toshitada Takahashi; Keigo Endo; Lloyd J Old
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma.
Cancer science 2006;97(11):1248-54.
2006: Jonathan Tammela; Akiko Uenaka; Toshiro Ono; Yuji Noguchi; Achim A Jungbluth; Paulette Mhawech-Fauceglia; Feng Qian; Sally Schneider; Sameer Sharma; Deborah Driscoll; Shashikant Lele; Lloyd J Old; Eiichi Nakayama; Kunle Odunsi
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
International journal of oncology 2006;29(4):903-10.
2006: Padmanee Sharma; Yu Shen; Sijin Wen; Dean F Bajorin; Victor E Reuter; Lloyd J Old; Achim A Jungbluth
Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5442-7.
2006: Klaus J Busam; Derya Kucukgol; Susannah Eastlake-Wade; Denise Frosina; Ruby Delgado; Achim A Jungbluth
Clusterin expression in primary and metastatic melanoma.
Journal of cutaneous pathology 2006;33(9):619-23.
2006: Zsuzsanna Varga; Jean-Philippe Theurillat; Valeriy Filonenko; Bernd Sasse; Bernhard Odermatt; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Dirk Jäger; Holger Moch
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2745-51.
2006: Catherine Barrow; Judy Browning; Duncan MacGregor; Ian D Davis; Sue Sturrock; Achim A Jungbluth; Jonathan Cebon
Tumor antigen expression in melanoma varies according to antigen and stage.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):764-71.
2006: Hearn J Cho; Otavia L Caballero; Sacha Gnjatic; Valéria C C Andrade; Gisele W Colleoni; André L Vettore; Hasina H Outtz; Sheila Fortunato; Nasser K Altorki; Cathy A Ferrera; Ramon Chua; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Andrew J G Simpson
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
Cancer immunity 2006;6():12.
2006: Sacha Gnjatic; Hiroyoshi Nishikawa; Achim A Jungbluth; Ali O Güre; Gerd Ritter; Elke Jäger; Alexander Knuth; Yao-Tseng Chen; Lloyd J Old
NY-ESO-1: review of an immunogenic tumor antigen.
Advances in cancer research 2006;95():1-30.
2006: Ran Zhuang; Yong Zhu; Liang Fang; Xue-Song Liu; Ying Tian; Li-Hua Chen; Wei-ming Ouyang; Xiao-Guang Xu; Jin-Long Jian; Ali O Güre; Sheila Fortunato; Gerd Ritter; Lloyd J Old; Andrew J G Simpson; Yao T Chen; Boquan Jin; Achim A Jungbluth
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Cancer immunity 2006;6():7.
2006: Matthew J Scanlan; Gerd Ritter; Beatrice W T Yin; Clarence Williams; Leonard S Cohen; Keren Coplan; Sheila R Fortunato; Denise Frosina; Sang-Yull Lee; Anne E Murray; Ramon Chua; Valeriy Filonenko; Eiichi Sato; Lloyd J Old; Achim A Jungbluth
Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
Cancer immunity 2006;6():2.
2005: Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian N Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine B Ambrosone; James L Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(51):18538-43.
2005: Rushika M Perera; Yoshitaka Narita; Frank B Furnari; Hui K Gan; Carmel Murone; Marika Ahlkvist; Rodney B Luwor; Antony W Burgess; Elisabeth Stockert; Achim A Jungbluth; Lloyd J Old; Webster K Cavenee; Andrew M Scott; Terrance G Johns
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6390-9.
2005: Achim A Jungbluth; Scott Ely; Maurizio DiLiberto; Ruben Niesvizky; Barbara Williamson; Denise Frosina; Yao-Tseng Chen; Nina Bhardwaj; Selina Chen-Kiang; Lloyd J Old; Hearn Jay Cho
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
Blood 2005;106(1):167-74.
2005: Matthias Wölfl; Achim A Jungbluth; Federico Garrido; Teresa Cabrera; Sharon Meyen-Southard; Rüdiger Spitz; Karen Ernestus; Frank Berthold
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Cancer immunology, immunotherapy : CII 2005;54(4):400-6.
2005: Klaus J Busam; Derya Kucukgöl; Eiichi Sato; Denise Frosina; Julie T Feldstein; Achim A Jungbluth
Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
The American journal of surgical pathology 2005;29(3):400-6.
2005: Klaus J Busam; Hui Zhao; Daniel G Coit; Derya Kucukgol; Achim A Jungbluth; Jennifer Nobrega; Agnes Viale
Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.
The Journal of investigative dermatology 2005;124(2):412-8.
2005: Dhananjay A Chitale; Achim A Jungbluth; David S Marshall; Mario Leitao Jr; Cyrus V Hedvat; Denise Kolb; Giulio C Spagnoli; Kristin Iversen; Robert A Soslow
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(1):119-26.
2004: Hilary A Vaughan; Suzanne Svobodova; Duncan MacGregor; Sue Sturrock; Achim A Jungbluth; Judy Browning; Ian D Davis; Phillip Parente; Yao-Tseng Chen; Elisabeth Stockert; Fiona St Clair; Lloyd J Old; Jonathan Cebon
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8396-404.
2004: Manju L Prasad; Achim A Jungbluth; Snehal G Patel; Kristin Iversen; Stacy Hoshaw-Woodard; Klaus J Busam
Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Head & neck 2004;26(12):1053-7.
2004: Yu Wang; Xiao-Jiang Wu; Ai-Lian Zhao; Yan-Hua Yuan; Yao-Tseng Chen; Achim A Jungbluth; Sacha Gnjatic; Darren Santiago; Gerd Ritter; Wei-Feng Chen; Lloyd J Old; Jia-Fu Ji
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
Cancer immunity 2004;4():11.
2004: Jonathan Tammela; Achim A Jungbluth; Feng Qian; Darren Santiago; Matthew J Scanlan; Bernadette Keitz; Deborah Driscoll; Kerry J Rodabaugh; Shashikant Lele; Lloyd J Old; Kunle Odunsi
SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Cancer immunity 2004;4():10.
2004: Shoichiro Fujita; Hisashi Wada; Achim A Jungbluth; Shuichiro Sato; Tetsuya Nakata; Yuji Noguchi; Yuichiro Doki; Masayoshi Yasui; Yurika Sugita; Takushi Yasuda; Masahiko Yano; Toshiro Ono; Yao-Tseng Chen; Masahiko Higashiyama; Sacha Gnjatic; Lloyd J Old; Eiichi Nakayama; Morito Monden
NY-ESO-1 expression and immunogenicity in esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6551-8.
2004: Ian D Davis; Weisan Chen; Heather Jackson; Phillip Parente; Mark Shackleton; Wendie Hopkins; Qiyuan Chen; Nektaria Dimopoulos; Tina Luke; Roger Murphy; Andrew M Scott; Eugene Maraskovsky; Grant McArthur; Duncan MacGregor; Sue Sturrock; Tsin Yee Tai; Simon Green; Andrew Cuthbertson; Darryl Maher; Lena Miloradovic; Susan V Mitchell; Gerd Ritter; Achim A Jungbluth; Yao-Tseng Chen; Sacha Gnjatic; Eric W Hoffman; Lloyd J Old; Jonathan Cebon
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10697-702.
2004: Terrance G Johns; Timothy E Adams; Jennifer Cochran; Nathan E Hall; Peter A Hoyne; Mark J Olsen; Yong-Sung Kim; Julie Rothacker; Edouard C Nice; Francesca Walker; Gerd Ritter; Achim A Jungbluth; Lloyd J Old; Colin W Ward; Antony W Burgess; K Dane Wittrup; Andrew M Scott
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.
The Journal of biological chemistry 2004;279(29):30375-84.
2004: Yurika Sugita; Hisashi Wada; Shoichiro Fujita; Tetsuya Nakata; Shuichiro Sato; Yuji Noguchi; Achim A Jungbluth; Masae Yamaguchi; Yao-Tseng Chen; Elisabeth Stockert; Sacha Gnjatic; Barbara Williamson; Matthew J Scanlan; Toshiro Ono; Isao Sakita; Masayoshi Yasui; Yasuo Miyoshi; Yasuhiro Tamaki; Nariaki Matsuura; Shinzaburo Noguchi; Lloyd J Old; Eiichi Nakayama; Morito Monden
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
Cancer research 2004;64(6):2199-204.
2004: Klaus J Busam; Jedd D Wolchok; Achim A Jungbluth; Paul B Chapman
Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma.
Journal of cutaneous pathology 2004;31(3):274-80.
2004: Djordje Atanackovic; Nasser K Altorki; Elisabeth Stockert; Barbara Williamson; Achim A Jungbluth; Erika Ritter; Darren Santiago; Cathy A Ferrara; Mitsutoshi Matsuo; Annamalai Selvakumar; Bo Dupont; Yao-Tseng Chen; Eric W Hoffman; Gerd Ritter; Lloyd J Old; Sacha Gnjatic
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3289-96.
2003: Terrance G Johns; Rodney B Luwor; Carmel Murone; Francesca Walker; Janet Weinstock; Angela A Vitali; Rushika M Perera; Achim A Jungbluth; Elisabeth Stockert; Lloyd J Old; Edouard C Nice; Antony W Burgess; Andrew M Scott
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15871-6.
2003: Padmanee Sharma; Sacha Gnjatic; Achim A Jungbluth; Barbara Williamson; Harry W Herr; Elisabeth Stockert; Guido Dalbagni; S Machele Donat; Victor E Reuter; Darren Santiago; Yao-Tseng Chen; Dean F Bajorin; Lloyd J Old
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Cancer immunity 2003;3():19.
2003: Christina M Lohmann; Wen-Jen Hwu; Kristin Iversen; Achim A Jungbluth; Klaus J Busam
Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens.
Melanoma research 2003;13(6):595-601.
2003: Maha Ayyoub; Michelle Brehm; Genevieve Metthez; Susan Talbot; Valérie Dutoit; Robert N Taub; Mary-Louise Keohan; Ali O Gure; Yao-Tseng Chen; Barbara Williamson; Achim A Jungbluth; Lloyd J Old; Charles Hesdorffer; Danila Valmori
SSX antigens as tumor vaccine targets in human sarcoma.
Cancer immunity 2003;3():13.
2003: Kunle Odunsi; Achim A Jungbluth; Elisabeth Stockert; Feng Qian; Sacha Gnjatic; Jonathan Tammela; Marilyn Intengan; Amy Beck; Bernadette Keitz; Darren Santiago; Barbara Williamson; Matthew J Scanlan; Gerd Ritter; Yao-Tseng Chen; Deborah Driscoll; Ashwani Sood; Shashikant Lele; Lloyd J Old
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Cancer research 2003;63(18):6076-83.
2003: Madhav V Dhodapkar; Keren Osman; Julie T Feldstein; Daniel A Filippa; Cyrus V Hedvat; Kristin Iversen; Denise Kolb; Matthew D Geller; Hani Hassoun; Tarun Kewalramani; Raymond Comenzo; Keren Coplan; Yao-Tseng Chen; Achim A Jungbluth
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
Cancer immunity 2003;3():9.
2003: Sang-Yull Lee; Yuichi Obata; Masahiro Yoshida; Elisabeth Stockert; Barbara Williamson; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Matthew J Scanlan
Immunomic analysis of human sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2651-6.
2003: Achim A Jungbluth; Elisabeth Stockert; H-J Su Huang; Vincent P Collins; Keren Coplan; Kristin Iversen; Denise Kolb; Terrance J Johns; Andrew M Scott; William J Gullick; Gerd Ritter; Leonard Cohen; Matthew J Scanlan; Webster K Cavenee; Lloyd J Old; Webster K Cavanee
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(2):639-44.
2002: Matthew J Scanlan; Ali O Gure; Achim A Jungbluth; Lloyd J Old; Yao-Tseng Chen
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Immunological reviews 2002;188():22-32.
2002: Christina M Lohmann; Kristin Iversen; Achim A Jungbluth; Marianne Berwick; Klaus J Busam
Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
The American journal of surgical pathology 2002;26(10):1351-7.
2002: Matthew J Scanlan; Sydney Welt; Claudia M Gordon; Yao-Tseng Chen; Ali O Gure; Elisabeth Stockert; Achim A Jungbluth; Gerd Ritter; Dirk Jäger; Elke Jäger; Alexander Knuth; Lloyd J Old
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
Cancer research 2002;62(14):4041-7.
2002: Achim A Jungbluth; Yao-Tseng Chen; Klaus J Busam; Keren Coplan; Denise Kolb; Kristin Iversen; Barbara Williamson; Frank K H van Landeghem; Elisabeth Stockert; Lloyd J Old
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.
International journal of cancer. Journal international du cancer 2002;99(6):839-45.
2002: Terrance G Johns; Elisabeth Stockert; Gerd Ritter; Achim A Jungbluth; H-J Su Huang; Webster K Cavenee; Fiona E Smyth; Cathrine M Hall; Nadine Watson; Edouard C Nice; William J Gullick; Lloyd J Old; Antony W Burgess; Andrew M Scott
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
International journal of cancer. Journal international du cancer 2002;98(3):398-408.
2002: Cristina R Antonescu; Klaus J Busam; Kristin Iversen; Denise Kolb; Keren Coplan; Giulio C Spagnoli; Marc Ladanyi; Lloyd J Old; Achim A Jungbluth
MAGE antigen expression in monophasic and biphasic synovial sarcoma.
Human pathology 2002;33(2):225-9.
2002: Cristina R Antonescu; Sylvia J Tschernyavsky; James M Woodruff; Achim A Jungbluth; Murray F Brennan; Marc Ladanyi
Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
The Journal of molecular diagnostics : JMD 2002;4(1):44-52.
2001: Achim A Jungbluth; Cristina R Antonescu; Klaus J Busam; Kristin Iversen; Denise Kolb; Keren Coplan; Yao-Tseng Chen; Elisabeth Stockert; Marc Ladanyi; Lloyd J Old
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
International journal of cancer. Journal international du cancer 2001;94(2):252-6.
2001: Kazuhiko Mishima; Terrance G Johns; Rodney B Luwor; Andrew M Scott; Elisabeth Stockert; Achim A Jungbluth; XD Ji; P Suvarna; J R Voland; Lloyd J Old; H-J Su Huang; Webster K Cavenee
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Cancer research 2001;61(14):5349-54.
2001: Achim A Jungbluth; Yao-Tseng Chen; Elisabeth Stockert; Klaus J Busam; Denise Kolb; Kristin Iversen; Keren Coplan; Barbara Williamson; N Altorki; Lloyd J Old
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.
International journal of cancer. Journal international du cancer 2001;92(6):856-60.
2001: Manju L Prasad; Achim A Jungbluth; Kristin Iversen; Andrew G Huvos; Klaus J Busam
Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
The American journal of surgical pathology 2001;25(6):782-7.
2001: Achim A Jungbluth; R King; David E Fisher; Kristin Iversen; Keren Coplan; Denise Kolb; Barbara Williamson; Yao-Tseng Chen; Elisabeth Stockert; Lloyd J Old; Klaus J Busam
Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(1):29-34.
2001: Klaus J Busam; Kristin Iversen; K C Coplan; Achim A Jungbluth
Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
The American journal of surgical pathology 2001;25(2):197-204.
2000: Rainer Grobholz; CS Verbeke; C Schleger; Kai Uwe Köhrmann; B Hein; G Wolf; Uwe Bleyl; Giulio C Spagnoli; Keren Coplan; Denise Kolb; Kristin Iversen; Achim A Jungbluth
Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminoma.
Urological research 2000;28(6):398-403.
2000: Achim A Jungbluth; Elisabeth Stockert; Yao-Tseng Chen; Denise Kolb; Kristin Iversen; Keren Coplan; Barbara Williamson; N Altorki; Klaus J Busam; Lloyd J Old
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.
British journal of cancer 2000;83(4):493-7.
2000: Klaus J Busam; S R Granter; Kristin Iversen; Achim A Jungbluth
Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
The American Journal of dermatopathology 2000;22(3):237-41.
2000: Klaus J Busam; Juan Rosai; Kristin Iversen; Achim A Jungbluth
Xanthogranulomas with inconspicuous foam cells and giant cells mimicking malignant melanoma: a clinical, histologic, and immunohistochemical study of three cases.
The American journal of surgical pathology 2000;24(6):864-9.
2000: Christoph Rader; G Ritter; S Nathan; M Elia; Ivan T Gout; Achim A Jungbluth; L S Cohen; Sydney Welt; Lloyd J Old; Carlos F Barbas
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies.
The Journal of biological chemistry 2000;275(18):13668-76.
2000: Klaus J Busam; Kristin Iversen; Marianne Berwick; Giulio C Spagnoli; Lloyd J Old; Achim A Jungbluth
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(4):459-65.
2000: Achim A Jungbluth; Klaus J Busam; Denise Kolb; Kristin Iversen; Keren Coplan; Yao-Tseng Chen; Giulio C Spagnoli; Lloyd J Old
Expression of MAGE-antigens in normal tissues and cancer.
International journal of cancer. Journal international du cancer 2000;85(4):460-5.
2000: Achim A Jungbluth; Kristin Iversen; Keren Coplan; Denise Kolb; Elisabeth Stockert; Yao-Tseng Chen; Lloyd J Old; Klaus J Busam
T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Pathology, research and practice 2000;196(4):235-42.
1999: Achim A Jungbluth; Kristin Iversen; Keren Coplan; Barbara Williamson; Yao-Tseng Chen; Elisabeth Stockert; Lloyd J Old; Klaus J Busam
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
Virchows Archiv : an international journal of pathology 1999;434(5):429-35.
1999: Klaus J Busam; Achim A Jungbluth
Melan-A, a new melanocytic differentiation marker.
Advances in anatomic pathology 1999;6(1):12-8.
1998: S Krishnamurthy; Achim A Jungbluth; Klaus J Busam; Juan Rosai
Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation.
The American journal of surgical pathology 1998;22(9):1078-82.
1998: Klaus J Busam; Yao-Tseng Chen; Lloyd J Old; Elisabeth Stockert; Kristin Iversen; Keren Coplan; Juan Rosai; R L Barnhill; Achim A Jungbluth
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
The American journal of surgical pathology 1998;22(8):976-82.
1998: Achim A Jungbluth; Klaus J Busam; William L Gerald; Elisabeth Stockert; Keren Coplan; Kristin Iversen; D P MacGregor; Lloyd J Old; Yao-Tseng Chen
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
The American journal of surgical pathology 1998;22(5):595-602.